Revival recalls canine milk replacers over variable vitamin D

Revival Animal Health’s April 17, 2026 recall of Breeder’s Edge® Foster Care® Canine and Shelter’s Choice® Canine Milk Replacers puts a spotlight on a high-risk corner of companion animal nutrition: products used for puppies that may be orphaned, fostered, or otherwise medically fragile. According to the company announcement posted by FDA, the recall was triggered after an investigation found variable vitamin D levels, with some products containing low levels and others elevated levels. The affected items were sold nationwide through online channels and retail pet stores. (fda.gov)

What makes this recall different from a more typical over-supplementation event is that the problem appears to run in two directions. FDA’s notice says the milk replacers had both low and elevated vitamin D levels, and the company had received two complaints of rickets at the time of the recall announcement. That combination matters because these products are often used during a narrow developmental window when nutritional errors can have outsized consequences. (fda.gov)

The recall covers seven product configurations across the two brands. FDA lists affected Shelter’s Choice Canine Milk Replacer products in 1 lb., 3.5 lb., and 8 lb. sizes, along with Breeder’s Edge Foster Care Canine Milk Replacer in 12 oz., 4.5 lb., 18 lb., and 20 lb. sizes, with best-by dates ranging from May 22, 2026 through February 5, 2028, depending on the SKU. Consumers were told to discontinue use immediately and contact the company for a full refund. Revival said the recall was being conducted with FDA’s knowledge. (fda.gov)

The clinical picture behind the recall is also unusually broad. FDA says dogs exposed to too much vitamin D may show vomiting, loss of appetite, increased thirst, increased urination, excessive drooling, and weight loss, and severe toxicity can progress to renal dysfunction. Separately, veterinary references note that vitamin D deficiency in young animals can contribute to rickets and abnormal bone development, though those conditions are uncommon when puppies receive properly formulated complete diets. In other words, veterinarians may need to think about both toxicosis and deficiency when evaluating exposed patients, especially puppies with orthopedic or growth concerns. (fda.gov)

Trade coverage has largely echoed the FDA posting, with pet food industry outlets emphasizing the manufacturing control issue rather than contamination by a pathogen or foreign material. Petfood Industry and Pet Food Processing both reported that the recall stemmed from variable vitamin D levels identified through an investigation, reinforcing that this was a nutrient-formulation or quality-control problem in a specialized neonatal product category. I did not find independent expert quotes specific to this recall from boarded veterinary nutritionists or major veterinary associations beyond the recall and reference materials themselves. (petfoodindustry.com)

Why it matters: For veterinary professionals, shelters, and rescue groups, this recall is a reminder that milk replacers are not interchangeable convenience products. They’re often used in patients with little physiologic margin for error, and both deficiency and excess can produce meaningful harm. Clinics may want to ask specifically about recalled milk replacers when working up puppies with poor growth, limb deformities, pain, polyuria/polydipsia, GI signs, or unexplained chemistry changes. Practices that support breeders, foster networks, or neonatal intensive care cases may also want to review what products clients are using, whether affected lots are still in circulation, and whether exposed puppies need monitoring based on age, duration of feeding, and clinical signs. (fda.gov)

There’s also a broader regulatory and operational angle. FDA’s recalls database continues to list the April 17, 2026 Revival Animal Health action among animal and veterinary recalls, and those listings can remain active until FDA determines the matter is terminated. For practices fielding client calls, that means the FDA recall page remains the key reference point for affected SKUs, best-by dates, and status updates. (fda.gov)

What to watch: The next signals to watch are whether FDA posts any updated recall status, whether additional adverse events emerge beyond the two rickets complaints cited on April 17, 2026, and whether Revival provides more detail on root cause, lot tracing, or support for affected pet parents and veterinary teams. (fda.gov)